CASI Pharmaceuticals Appoints James Huang as Non-Executive Chairman

Reuters
2025.11.19 14:00
portai
I'm PortAI, I can summarize articles.

CASI Pharmaceuticals Inc. has appointed James Huang as Non-Executive Chairman of its Board of Directors, effective November 17, 2025. Dr. Wei-Wu He will step down as Executive Chairman but remain on the Board. This leadership change was announced via ACCESS Newswire.

CASI Pharmaceuticals Inc. has appointed James Huang as Non-Executive Chairman of its Board of Directors, effective November 17, 2025. Dr. Wei-Wu He will step down as Executive Chairman but will remain a member of the Board. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CASI Pharmaceuticals Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1103872) on November 19, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.